Cancer Research UK has awarded a 20-million-pound grant (about $26 million U.S.) to a team of international investigators, including Vanderbilt’s James Goldenring, MD, PhD, to study inflammation-related cancers.
Goldenring and other co-investigators from the United States, United Kingdom, Canada and Israel will seek to develop strategies for preventing cancer in patients with chronic inflammation and to devise new treatments for those cancers. Their initiative is one of three new projects to have been awarded a multimillion-pound grant as part of the charity’s global Grand Challenge, an ambitious endeavor that launched in 2017 with four previous grants of a similar scale.